Oral cannabinoid formulations
US9345771B2 · kind B2 · utility
14Cited by
5References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 4, 2012 |
| Grant date | May 24, 2016 |
| Priority date | — |
| Expiry date | Dec 8, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/353
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Oral cannabinoid formulations, including an aqueous-based oral dronabinol solution, that are stable at room or refrigerated temperatures and may possess improved in vivo absorption profiles with faster onset and lower inter-subject variability.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.